Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 81

Similar articles for PubMed (Select 23530466)

1.

Pharmacovigilance: an active surveillance system to proactively identify risks for adverse events.

Moses C, Celi LA, Marshall J.

Popul Health Manag. 2013 Jun;16(3):147-9. doi: 10.1089/pop.2012.0100. Epub 2013 Mar 26. No abstract available.

PMID:
23530466
2.

Pharmacovigilance and post-black market surveillance.

Langlitz N.

Soc Stud Sci. 2009 Jun;39(3):395-420.

PMID:
19848184
3.

Alleged isotretinoin-associated inflammatory bowel disease: disproportionate reporting by attorneys to the Food and Drug Administration Adverse Event Reporting System.

Stobaugh DJ, Deepak P, Ehrenpreis ED.

J Am Acad Dermatol. 2013 Sep;69(3):393-8. doi: 10.1016/j.jaad.2013.04.031. Epub 2013 May 14.

PMID:
23683730
4.

Suboptimal reporting of adverse medical events to the FDA Adverse Events Reporting System by nurse practitioners and physician assistants.

Ehrenpreis ED, Sifuentes H, Ehrenpreis JE, Smith ZL, Marshall ML.

Expert Opin Drug Saf. 2012 Mar;11(2):177-83. doi: 10.1517/14740338.2012.650165. Epub 2012 Feb 8.

PMID:
22316142
5.

OpenVigil--free eyeballs on AERS pharmacovigilance data.

Böhm R, Höcker J, Cascorbi I, Herdegen T.

Nat Biotechnol. 2012 Feb 8;30(2):137-8. doi: 10.1038/nbt.2113. No abstract available.

PMID:
22318027
6.

Forensic pharmacovigilance and substandard or counterfeit drugs.

Labadie J.

Int J Risk Saf Med. 2012;24(1):37-9. doi: 10.3233/JRS-2012-0551.

PMID:
22436258
7.
8.

Advancing the science of pharmacovigilance.

Honig PK.

Clin Pharmacol Ther. 2013 Jun;93(6):474-5. doi: 10.1038/clpt.2013.60.

PMID:
23689213
9.

Hypersensitivity reactions to anticancer agents: data mining of the public version of the FDA adverse event reporting system, AERS.

Kadoyama K, Kuwahara A, Yamamori M, Brown JB, Sakaeda T, Okuno Y.

J Exp Clin Cancer Res. 2011 Oct 5;30:93. doi: 10.1186/1756-9966-30-93.

10.

Informatic tools and approaches in postmarketing pharmacovigilance used by FDA.

Weaver J, Willy M, Avigan M.

AAPS J. 2008;10(1):35-41. doi: 10.1208/s12248-007-9004-5. Epub 2008 Jan 25. Review.

11.

Automated support for pharmacovigilance: a proposed system.

Bright RA, Nelson RC.

Pharmacoepidemiol Drug Saf. 2002 Mar;11(2):121-5.

PMID:
11998536
12.

Pharmacovigilance in Europe and North America: divergent approaches.

Wiktorowicz M, Lexchin J, Moscou K.

Soc Sci Med. 2012 Jul;75(1):165-70. doi: 10.1016/j.socscimed.2011.11.046. Epub 2012 Apr 3.

PMID:
22521677
13.

Unleashing the mini-sentinel.

Mullard A.

Nat Rev Drug Discov. 2012 Mar 30;11(4):255-7. doi: 10.1038/nrd3713. No abstract available.

PMID:
22460110
14.

Logistic regression in signal detection: another piece added to the puzzle.

Caster O, Norén GN, Madigan D, Bate A.

Clin Pharmacol Ther. 2013 Sep;94(3):312. doi: 10.1038/clpt.2013.107. Epub 2013 May 21. No abstract available.

PMID:
23695184
15.

Autologous cultured chondrocytes: adverse events reported to the United States Food and Drug Administration.

Wood JJ, Malek MA, Frassica FJ, Polder JA, Mohan AK, Bloom ET, Braun MM, Coté TR.

J Bone Joint Surg Am. 2006 Mar;88(3):503-7.

PMID:
16510814
16.

Response to "Logistic regression in signal detection: another piece added to the puzzle".

Harpaz R, DuMouchel W, LePendu P, Bauer-Mehren A, Ryan P, Shah NH.

Clin Pharmacol Ther. 2013 Sep;94(3):313. doi: 10.1038/clpt.2013.125. Epub 2013 Jun 12. No abstract available.

PMID:
23756371
17.

Pharmacovigilance and safety aspects of sevoflurane.

Kharasch ED.

Acta Anaesthesiol Scand Suppl. 1997;111:146-8. No abstract available.

PMID:
9420990
18.

Reporting rates of yellow fever vaccine 17D or 17DD-associated serious adverse events in pharmacovigilance data bases: systematic review.

Thomas RE, Lorenzetti DL, Spragins W, Jackson D, Williamson T.

Curr Drug Saf. 2011 Jul;6(3):145-54. Review.

PMID:
22122389
19.

U.S. postmarketing pharmacovigilance compliance in the midst of regulatory uncertainty.

Goldman SA.

Food Drug Law J. 2007;62(3):513-28. No abstract available.

PMID:
17915393
20.

Monitoring adverse reactions to veterinary drugs. Pharmacovigilance.

Bataller N, Keller WC.

Vet Clin North Am Food Anim Pract. 1999 Mar;15(1):13-30, vii-viii. Review.

PMID:
10088209
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk